We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bellevue Healthcare Trust plc (BBH) Ord GBP0.01

Sell:136.40p Buy:136.80p 0 Change: 2.20p (1.64%)
FTSE 250:1.23%
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Redemption

Bellevue Healthcare Trust plc Ord GBP0.01

Type:
Redemption
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 2 Aug 2024)

Bellevue Healthcare Trust plc offers an annual optional redemption facility whereby shareholders can elect to redeem some or all of their shares for cash on the last business day in November each year (or such other date as the Directors may determine). The next annual redemption point is 22 November 2024. You have two options to consider before our noon on Thursday 10 October 2024 deadline.

 

Please note, the redemption price will be calculated at the director’s discretion on either of the following basis:

 

EITHER The redemption price shall be equal to the dealing value per ordinary share calculated as at the appropriate valuation point on the appropriate redemption point

 

OR The directors may elect to calculate the redemption price by reference to the amount generated upon the realisation of a redemption pool created for the purpose of funding the redemption.

 

What are my options?

 

Option 1 – Redeem a number of shares. If you wish to redeem a number of shares please give us your instruction by noon on Thursday 10 October 2024, at which point any redeemed shares will be removed from your portfolio.

 

Option 2 – Take no action. If you do not return an instruction no shares will be redeemed on your behalf and your holding will remain unchanged.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:136.40p
Buy:136.80p
Change: 2.20p (1.64%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Redemption

Bellevue Healthcare Trust plc Ord GBP0.01

Type:
Redemption
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 2 Aug 2024)

Bellevue Healthcare Trust plc offers an annual optional redemption facility whereby shareholders can elect to redeem some or all of their shares for cash on the last business day in November each year (or such other date as the Directors may determine). The next annual redemption point is 22 November 2024. You have two options to consider before our noon on Thursday 10 October 2024 deadline.

 

Please note, the redemption price will be calculated at the director’s discretion on either of the following basis:

 

EITHER The redemption price shall be equal to the dealing value per ordinary share calculated as at the appropriate valuation point on the appropriate redemption point

 

OR The directors may elect to calculate the redemption price by reference to the amount generated upon the realisation of a redemption pool created for the purpose of funding the redemption.

 

What are my options?

 

Option 1 – Redeem a number of shares. If you wish to redeem a number of shares please give us your instruction by noon on Thursday 10 October 2024, at which point any redeemed shares will be removed from your portfolio.

 

Option 2 – Take no action. If you do not return an instruction no shares will be redeemed on your behalf and your holding will remain unchanged.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:136.40p
Buy:136.80p
Change: 2.20p (1.64%)
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Redemption

Bellevue Healthcare Trust plc Ord GBP0.01

Type:
Redemption
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 2 Aug 2024)

Bellevue Healthcare Trust plc offers an annual optional redemption facility whereby shareholders can elect to redeem some or all of their shares for cash on the last business day in November each year (or such other date as the Directors may determine). The next annual redemption point is 22 November 2024. You have two options to consider before our noon on Thursday 10 October 2024 deadline.

 

Please note, the redemption price will be calculated at the director’s discretion on either of the following basis:

 

EITHER The redemption price shall be equal to the dealing value per ordinary share calculated as at the appropriate valuation point on the appropriate redemption point

 

OR The directors may elect to calculate the redemption price by reference to the amount generated upon the realisation of a redemption pool created for the purpose of funding the redemption.

 

What are my options?

 

Option 1 – Redeem a number of shares. If you wish to redeem a number of shares please give us your instruction by noon on Thursday 10 October 2024, at which point any redeemed shares will be removed from your portfolio.

 

Option 2 – Take no action. If you do not return an instruction no shares will be redeemed on your behalf and your holding will remain unchanged.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company may also invest in ADRs, or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies.
Security Weight
CareDx Inc 7.58%
Tandem Diabetes Care Inc 6.63%
UnitedHealth Group Inc 6.42%
Bio-Rad Laboratories Inc Class A 5.74%
Charles River Laboratories International Inc 5.35%
Evolent Health Inc Class A 5.28%
Axsome Therapeutics Inc 5.21%
Exact Sciences Corp 5.05%
Option Care Health Inc 5.02%
Insmed Inc 4.74%
Sector Weight
Healthcare 100.00%
Country Weight
United States 95.29%
United Kingdom 2.94%
Hong Kong 1.55%
China 0.23%

Fee Structure

Management fee payable monthly in arrear and is at the rate of one-twelfth of 0.95% per calendar month of the Market Capitalisation.There is no performance fee payable to Bellevue. The agreement is terminable on 12 months notice.

Dividend Policy

The Company will set a target dividend each financial year equal to 3.5% of NAV as at the last day of the preceding financial year of the Company. The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August and proposed in February/March and paid in March/April in each year.

ASSET SPLIT

Total number of holdings: 4.

Trust Manager

Paul Major

Manager Bio

Paul has 18 years of experience in the healthcare sector on the sell-side and was top-rated by a number of institutional investment clients. He was one of the first research partners at Redburn, Europe’s leading independent research firm. His work there included bespoke projects on healthcare portfolio construction for several institutions. Paul was previously an analyst and corporate financier at UBS Warburg and studied biochemistry.

Board Of Directors

Randeep Singh GrewalChairman, Paul Southgate, Josephine Dixon, Katherine Bolsover, Antony Young

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.